These data demonstrate that deletion of the GCLC protein can be induced in the liver of adult animals
Therefore, use of rhEPO for treatment of tissue injury is limited by the potential side effects of increased erythrocyte mass and endothelial cell activation, which, in combination with activated platelet production, predisposes to thrombosis (6,7)
Do not begin an NAD or glutathione protocol during cancer evaluation or treatment without the oncology team
Other groups who may benefit include: Patients following gastric surgery (gastrectomy, bariatric procedures) where intrinsic factor production or absorption sites are compromised Individuals with malabsorption disorders such as Crohn's disease, coeliac disease, or chronic pancreatitis Strict vegans and vegetarians with dietary insufficiency, though oral supplementation is usually tried first Elderly patients with atrophic gastritis or reduced gastric acid production Patients on long-term metformin or proton pump inhibitors, which can impair B12 absorption [6] [8] Individuals with nitrous oxide exposure (recreational or medical), which can cause functional B12 deficiency Diagnosis typically involves serum B12 measurement, with levels below approximately 148 pmol/L (though thresholds vary between laboratories) generally indicating deficiency

Selecting the appropriate quantity depends on the scale and duration of the research programme: GHK-CU 50mg is suited to smaller-scale studies, preliminary investigations, method development, and research programmes that are in the early stages of incorporating this compound into their experimental design
S2CID 42397848